New Reduced Drinking Goals in Alcohol Pharmacotherapy Trials—A Novel Public-Private Effort and FDA Approval Process
This Viewpoint describes the work of a public-private partnership to establish a reduced drinking level–based end point for clinical trials of alcohol use disorder treatment.
Authors
- Stephanie S. O’Malley (ORCID: https://orcid.org/0000-0003-0988-5522)
- Karl Mann (ORCID: https://orcid.org/0000-0002-2087-1976)
- Bernard L. Silverman (ORCID: https://orcid.org/0000-0002-5833-0147)
- Raymond F. Anton (ORCID: https://orcid.org/0000-0003-3417-6576)
Institutions
- Medical University of South Carolina (US)
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
- Yale University (US)
- RF Laboratories (United States) (US)
- Central Institute of Mental Health (DE)
Publication Details
- Journal
- JAMA Psychiatry
- Published
- 2025-09-17
- DOI
- https://doi.org/10.1001/jamapsychiatry.2025.2515
- Citations
- 1
- Primary Topic
- Substance Abuse Treatment and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.35